Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Author's Reply
    • Simon DM Chen, Ophthalmologist
    • Other Contributors:
      • Jonathan Lochhead, CK Patel, Peggy Frith

    Dear Editor

    We thank BV Kumar and S Prasad for their interest in our report describing the successful treatment of macular oedema (MO) secondary to branch retinal vein occlusion (BRVO) with intravitreal triamcinolone injection (IVTI).[1]

    Although definitively establishing a clinical diagnosis of posterior vitreous detachment (PVD) may be problematic, our patient did not have a Weiss ring and no eviden...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    How does intravitreal triamcinolone work?
    • Somdutt Prasad, Consultant Ophthalmologist
    • Other Contributors:
      • B V Kumar, S Prasad

    Dear Editor

    SDM Chen and colleagues present a case of successful treatment of macular oedema in the setting of ischaemic branch retinal vein occlusion (BRVO).[1]

    Intravitreal triamcinolone is increasingly being used as part of our therapeutic armaterium in a wide range of conditions. However it’s mode of action is still to be fully elucidated. It is known that the induction of a posterior vitreous detachme...

    Show More
    Conflict of Interest:
    None declared.